The right test for the right patients

QHerit helps you and your patients understand their genetic risks so that together, you can make informed decisions. It’s built on industry-leading NGS and a robust and growing genomics database that tests for disorders recommended by ACOG, ACMG, and Jewish advocacy groups for carrier screening.

This includes testing for spinal muscular atrophy, cystic fibrosis, and other disorders that can play an important role in your patients’ healthcare and family planning. QHerit focuses on disorders that:

  • Have potentially devastating consequences
  • Result in early death
  • Create a need for significant early intervention

QHerit provides a clear picture, testing only clinically relevant variants within genes.

Alpha-Thalassemia

 

Beta-Hemoglobinopathies
(Including Sickle Cell Disease)

Bloom Syndrome

Canavan Disease

Cystic Fibrosis (CF)

Dihydrolipoamide Dehydrogenase Deficiency (DLD Deficiency)

Familial Dysautonomia

Familial Hyperinsulinism

Fanconi Anemia Type C

Fragile X Syndrome

Gaucher Disease

 

Glycogen Storage Disease Type Ia

Joubert Syndrome 2

Maple Syrup Urine Disease

Mucolipidosis Type IV

Nemaline Myopathy

Niemann-Pick Disease, Types A & B

Spinal Muscular Atrophy (SMA)

Tay-Sachs Disease

Usher Syndrome, Type 1F

Usher Syndrome, Type IIIA

Walker-Warburg Syndrome

 

See brief descriptions of each condition here.

Please visit QHerit.com/ClinicalInfo for additional clinical information and references.